The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasms

D. A. Dillon, C. C. Johnson, Mark Topazian, G. Tallini, D. L. Rimm, J. C. Costa

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

PURPOSE: Mutations involved in neoplastic progression may be abre to serve as markers for the presence of small numbers of neoplastic cells that would otherwise escape detection in diagnostic assays. Previous retrospective studies have suggested that the sensitivity of the cytologic diagnosis of pancreatic and biliary tract carcinomas is improved when analysis includes Ki-ras exon 1, which is commonly mutated in these neoplasms. We report our experience with the systematic prospective apprication of Ki-ras gene analysis to the evaluation of fine-needre aspirates and brushings from the pancreatobiliary tract. MATERIALS AND METHODS: Between September 1996 and April 1999, 75 pancreatic fine-needle aspirates and common bile duct brushings submitted for routine cytologic diagnosis were also evaluated for mutations in Ki-ras exon 1 by polymerase chain reaction/single-strand conformation polymorphism analysis. After routine preparation of the specimens, residual material was used for molecular analysis. Results are compared with the morphologic diagnosis and available clinical information. RESULTS: Single-strand conformation polymorphism mutation patterns in Ki-ras were detected in 22 of the 70 consecutive clinical specimens with adequate DNA and at least 6 months of available clinical follow-up. Sensitivity, specificity, and positive predictive value for the presence of concurrent or subsequent pancreatobiliary carcinoma were 33%, 97%, and 93%, respectively, for definitive cytologic diagnosis alone, and 53%, 97%, and 95% for positive Ki-ras single-strand conformation polymorphism mutation pattern atone. If definitive positive cytology or atypical/suspicious cytology with a positive Ki-ras single-strand conformation polymorphism mutation pattern is used, sensitivity is 55%, specificity is 97%, and positive predictive value is 96% for the presence of pancreatobiliary carcinoma. DISCUSSION: Results support the routine use of Ki-ras mutational analysis to increase the sensitivity of the cytologic evaluation of pancreatobiliary fine-needle aspirates and common bile duct brushings with atypical or suspicious morphology without compromising specificity.

Original languageEnglish (US)
Pages (from-to)294-301
Number of pages8
JournalCancer Journal
Volume6
Issue number5
StatePublished - Nov 20 2000
Externally publishedYes

Fingerprint

Mutation
Common Bile Duct
Neoplasms
Carcinoma
Needles
Cell Biology
Exons
ras Genes
Biliary Tract
Retrospective Studies
Cell Count
Sensitivity and Specificity
Polymerase Chain Reaction
DNA

Keywords

  • Biliary tract
  • Carcinoma
  • Diagnosis
  • FNA
  • K-ras
  • Mutation
  • Pancreas

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Dillon, D. A., Johnson, C. C., Topazian, M., Tallini, G., Rimm, D. L., & Costa, J. C. (2000). The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasms. Cancer Journal, 6(5), 294-301.

The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasms. / Dillon, D. A.; Johnson, C. C.; Topazian, Mark; Tallini, G.; Rimm, D. L.; Costa, J. C.

In: Cancer Journal, Vol. 6, No. 5, 20.11.2000, p. 294-301.

Research output: Contribution to journalArticle

Dillon, DA, Johnson, CC, Topazian, M, Tallini, G, Rimm, DL & Costa, JC 2000, 'The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasms', Cancer Journal, vol. 6, no. 5, pp. 294-301.
Dillon DA, Johnson CC, Topazian M, Tallini G, Rimm DL, Costa JC. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasms. Cancer Journal. 2000 Nov 20;6(5):294-301.
Dillon, D. A. ; Johnson, C. C. ; Topazian, Mark ; Tallini, G. ; Rimm, D. L. ; Costa, J. C. / The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasms. In: Cancer Journal. 2000 ; Vol. 6, No. 5. pp. 294-301.
@article{878c26ef6bef4385bad658bef9db8930,
title = "The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasms",
abstract = "PURPOSE: Mutations involved in neoplastic progression may be abre to serve as markers for the presence of small numbers of neoplastic cells that would otherwise escape detection in diagnostic assays. Previous retrospective studies have suggested that the sensitivity of the cytologic diagnosis of pancreatic and biliary tract carcinomas is improved when analysis includes Ki-ras exon 1, which is commonly mutated in these neoplasms. We report our experience with the systematic prospective apprication of Ki-ras gene analysis to the evaluation of fine-needre aspirates and brushings from the pancreatobiliary tract. MATERIALS AND METHODS: Between September 1996 and April 1999, 75 pancreatic fine-needle aspirates and common bile duct brushings submitted for routine cytologic diagnosis were also evaluated for mutations in Ki-ras exon 1 by polymerase chain reaction/single-strand conformation polymorphism analysis. After routine preparation of the specimens, residual material was used for molecular analysis. Results are compared with the morphologic diagnosis and available clinical information. RESULTS: Single-strand conformation polymorphism mutation patterns in Ki-ras were detected in 22 of the 70 consecutive clinical specimens with adequate DNA and at least 6 months of available clinical follow-up. Sensitivity, specificity, and positive predictive value for the presence of concurrent or subsequent pancreatobiliary carcinoma were 33{\%}, 97{\%}, and 93{\%}, respectively, for definitive cytologic diagnosis alone, and 53{\%}, 97{\%}, and 95{\%} for positive Ki-ras single-strand conformation polymorphism mutation pattern atone. If definitive positive cytology or atypical/suspicious cytology with a positive Ki-ras single-strand conformation polymorphism mutation pattern is used, sensitivity is 55{\%}, specificity is 97{\%}, and positive predictive value is 96{\%} for the presence of pancreatobiliary carcinoma. DISCUSSION: Results support the routine use of Ki-ras mutational analysis to increase the sensitivity of the cytologic evaluation of pancreatobiliary fine-needle aspirates and common bile duct brushings with atypical or suspicious morphology without compromising specificity.",
keywords = "Biliary tract, Carcinoma, Diagnosis, FNA, K-ras, Mutation, Pancreas",
author = "Dillon, {D. A.} and Johnson, {C. C.} and Mark Topazian and G. Tallini and Rimm, {D. L.} and Costa, {J. C.}",
year = "2000",
month = "11",
day = "20",
language = "English (US)",
volume = "6",
pages = "294--301",
journal = "Cancer Journal (United States)",
issn = "1528-9117",
publisher = "Association Pour le Developpement de la Communication Cancerologique",
number = "5",

}

TY - JOUR

T1 - The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasms

AU - Dillon, D. A.

AU - Johnson, C. C.

AU - Topazian, Mark

AU - Tallini, G.

AU - Rimm, D. L.

AU - Costa, J. C.

PY - 2000/11/20

Y1 - 2000/11/20

N2 - PURPOSE: Mutations involved in neoplastic progression may be abre to serve as markers for the presence of small numbers of neoplastic cells that would otherwise escape detection in diagnostic assays. Previous retrospective studies have suggested that the sensitivity of the cytologic diagnosis of pancreatic and biliary tract carcinomas is improved when analysis includes Ki-ras exon 1, which is commonly mutated in these neoplasms. We report our experience with the systematic prospective apprication of Ki-ras gene analysis to the evaluation of fine-needre aspirates and brushings from the pancreatobiliary tract. MATERIALS AND METHODS: Between September 1996 and April 1999, 75 pancreatic fine-needle aspirates and common bile duct brushings submitted for routine cytologic diagnosis were also evaluated for mutations in Ki-ras exon 1 by polymerase chain reaction/single-strand conformation polymorphism analysis. After routine preparation of the specimens, residual material was used for molecular analysis. Results are compared with the morphologic diagnosis and available clinical information. RESULTS: Single-strand conformation polymorphism mutation patterns in Ki-ras were detected in 22 of the 70 consecutive clinical specimens with adequate DNA and at least 6 months of available clinical follow-up. Sensitivity, specificity, and positive predictive value for the presence of concurrent or subsequent pancreatobiliary carcinoma were 33%, 97%, and 93%, respectively, for definitive cytologic diagnosis alone, and 53%, 97%, and 95% for positive Ki-ras single-strand conformation polymorphism mutation pattern atone. If definitive positive cytology or atypical/suspicious cytology with a positive Ki-ras single-strand conformation polymorphism mutation pattern is used, sensitivity is 55%, specificity is 97%, and positive predictive value is 96% for the presence of pancreatobiliary carcinoma. DISCUSSION: Results support the routine use of Ki-ras mutational analysis to increase the sensitivity of the cytologic evaluation of pancreatobiliary fine-needle aspirates and common bile duct brushings with atypical or suspicious morphology without compromising specificity.

AB - PURPOSE: Mutations involved in neoplastic progression may be abre to serve as markers for the presence of small numbers of neoplastic cells that would otherwise escape detection in diagnostic assays. Previous retrospective studies have suggested that the sensitivity of the cytologic diagnosis of pancreatic and biliary tract carcinomas is improved when analysis includes Ki-ras exon 1, which is commonly mutated in these neoplasms. We report our experience with the systematic prospective apprication of Ki-ras gene analysis to the evaluation of fine-needre aspirates and brushings from the pancreatobiliary tract. MATERIALS AND METHODS: Between September 1996 and April 1999, 75 pancreatic fine-needle aspirates and common bile duct brushings submitted for routine cytologic diagnosis were also evaluated for mutations in Ki-ras exon 1 by polymerase chain reaction/single-strand conformation polymorphism analysis. After routine preparation of the specimens, residual material was used for molecular analysis. Results are compared with the morphologic diagnosis and available clinical information. RESULTS: Single-strand conformation polymorphism mutation patterns in Ki-ras were detected in 22 of the 70 consecutive clinical specimens with adequate DNA and at least 6 months of available clinical follow-up. Sensitivity, specificity, and positive predictive value for the presence of concurrent or subsequent pancreatobiliary carcinoma were 33%, 97%, and 93%, respectively, for definitive cytologic diagnosis alone, and 53%, 97%, and 95% for positive Ki-ras single-strand conformation polymorphism mutation pattern atone. If definitive positive cytology or atypical/suspicious cytology with a positive Ki-ras single-strand conformation polymorphism mutation pattern is used, sensitivity is 55%, specificity is 97%, and positive predictive value is 96% for the presence of pancreatobiliary carcinoma. DISCUSSION: Results support the routine use of Ki-ras mutational analysis to increase the sensitivity of the cytologic evaluation of pancreatobiliary fine-needle aspirates and common bile duct brushings with atypical or suspicious morphology without compromising specificity.

KW - Biliary tract

KW - Carcinoma

KW - Diagnosis

KW - FNA

KW - K-ras

KW - Mutation

KW - Pancreas

UR - http://www.scopus.com/inward/record.url?scp=0033767525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033767525&partnerID=8YFLogxK

M3 - Article

C2 - 11079168

AN - SCOPUS:0033767525

VL - 6

SP - 294

EP - 301

JO - Cancer Journal (United States)

JF - Cancer Journal (United States)

SN - 1528-9117

IS - 5

ER -